Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by The Lancet, The Lancet Gastroenterology, and Amp; Hepatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet, The Lancet Gastroenterology, and Amp; Hepatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

In conversation with... Julia Mayerle

26:52
 
Share
 

Manage episode 489690382 series 2608052
Content provided by The Lancet, The Lancet Gastroenterology, and Amp; Hepatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet, The Lancet Gastroenterology, and Amp; Hepatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk patients.

  continue reading

90 episodes

Artwork
iconShare
 
Manage episode 489690382 series 2608052
Content provided by The Lancet, The Lancet Gastroenterology, and Amp; Hepatology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet, The Lancet Gastroenterology, and Amp; Hepatology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk patients.

  continue reading

90 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play